Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays

Pharmaindustrie: Novartis stoppt nach Todesfällen Studien zu Zelltherapie

Mit einer Zelltherapie wollte der Konzern Autoimmunerkrankungen behandeln. Doch bei klinischen Studien soll es zu Todesfällen gekommen sein. Darum wird die Entwicklung vorerst gestoppt.

2026-09-01 ·handelsblatt.com

'Baby Tommy's here, Chelsea's not': First-time mum dies in childbirth

Chelsea McGillivray, from Rutherglen, South Lanarkshire, fell into cardiac arrest during labour after what was believed to be a textbook pregnancy.

2026-09-01 ·bbc.co.uk

Rising cancer diagnoses reflect population growth and ageing but mortality rate improving

Survival rates now up to 30 per cent higher than in the 1990s, study shows

2026-09-01 ·irishtimes.com

HLB's liver cancer therapy proves effective across all age groups in new study

HLB Group's liver cancer combination therapy showed consistent treatment benefits regardless of patient age, including in patients under 40, according to a new subgroup analysis to be presented this…

2026-09-01 ·koreatimes.co.kr

‘Stigma has to go’: Court flags rules that denied HIV+ woman promotion in CRPF

2026-09-01 ·indianexpress.com